Early Experience of Treprostinil Dry‐Powdered Inhaler in Patients With Pulmonary Hypertension Related to Fibrosing Interstitial Lung Disease at a Tertiary Referral Center

Documenti analoghi

• What I Learned From the Study of Sex Differences in Pulmonary Hypertension: How Following the Data and the Kindness of Strangers Helped Me Overcome Self‐Doubt and Imposter Syndrome
  di: Tim Lahm
  Pubblicazione: (2025)
• What I Learned From the Study of Sex Differences in Pulmonary Hypertension: How Following the Data and the Kindness of Strangers Helped Me Overcome Self‐Doubt and Imposter Syndrome
  di: Tim Lahm
  Pubblicazione: (2025)
• Adherence to the ISHLT Protocol for the Referral of Patients with Idiopathic Pulmonary Fibrosis to the Transplantation Center among of Czech Centers for Interstitial Lung Diseases
  di: Martina Sterclova, et al.
  Pubblicazione: (2024)
• Pulmonary Hypertension Associated With COVID‐19 Interstitial Lung Disease
  di: Shreeya Mehta, et al.
  Pubblicazione: (2026)
• Real‐World Dosing and Persistence of Oral Treprostinil Initiation Strategies in Patients With Pulmonary Arterial Hypertension
  di: Daniel J. Lachant, et al.
  Pubblicazione: (2025)